Subtype
Ovarian Neoplasm
CI-CAN-00001335Explore in graph →
Non-malignant746 active trials5 approved drugs94 evidence items
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00001335Explore in graph →
Clinical trials
3,430 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT05991752 | Health-Economic Evaluation of Early Diagnosis of Epithalial Ovarian Cancer Recurrence Using the ROMA Score: a Prospective Multicenter Randomized Trial(ROMECO) | withdrawn | N/A | 0 | University Hospital, ToursOTHER | 0 | Jun 11, 2026 | clinicaltrials |
| NCT07642791 | Safety of Opportunistic Salpingectomy During Elective Laparoscopic Cholecystectomy. | active not recruiting | N/A | 300 | University of ZurichOTHER | 1 | Jun 11, 2026 |
| clinicaltrials |
| NCT07639801 | 68Ga-FAPI-PSMA PET Imaging for the Diagnosis of Solid Tumors | not yet recruiting | N/A | 20 | Peking University Cancer Hospital & InstituteOTHER | 0 | Jun 10, 2026 | clinicaltrials |
| NCT07636200 | The EASE Study: Randomized Trial of a Novel Approach to Addressing Fear of Progression in Advanced Cancer(EASE) | recruiting | N/A | 250 | University of Colorado, BoulderOTHER | 1 | Jun 9, 2026 | clinicaltrials |
| NCT03598946 | Urinary Human Papilloma Virus Test in the General Population in Brittany(PapU-Access) | terminated | N/A | 1,809 | University Hospital, BrestOTHER | 1 | Jun 8, 2026 | clinicaltrials |
| NCT04454450 | Using Advanced Imaging Studies to Develop a Profile of High-grade Serous Ovarian Cancer | active not recruiting | N/A | 10 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 2, 2026 | clinicaltrials |
| NCT05056077 | Improving Nutrition and Physical Activity for Cancer Survivors (Tools To Be Fit)(TTBF) | active not recruiting | N/A | 353 | University of California, San FranciscoOTHER | 1 | Jun 2, 2026 | clinicaltrials |
| NCT07120945 | Hugo™ Robotic-Assisted Surgery (RAS) System in Gynecological Subjects (Embrace Gynecology)(Embrace Gyn) | active not recruiting | N/A | 70 | Medtronic - MITGINDUSTRY | 1 | Jun 2, 2026 | clinicaltrials |
| NCT05364879 | Prehabilitation for Ovarian Cancer Patients | recruiting | N/A | 108 | Nova Scotia Health AuthorityOTHER | 1 | Jun 1, 2026 | clinicaltrials |
| NCT07616310 | Rectosigmoid Lesion Excision vs. Resection: A Non-Inferiority Randomized Comparison in Advanced Ovarian Cancer(RSEnTrail) | recruiting | N/A | 300 | Second Affiliated Hospital, Zhejiang University, School of MedicineOTHER | 1 | Jun 1, 2026 | clinicaltrials |
| NCT07609082 | Evaluating the Feasibility of Prehabilitation Delivery Models for Patients Preparing for Ovarian Cancer Surgery(ADAPT-OC) | not yet recruiting | N/A | 36 | Jordan LeitchOTHER | 1 | May 27, 2026 | clinicaltrials |
| NCT06760507 | Evaluating an Evidence-Based Family History Screening Program Adapted to Increase Reach and Uptake of Screening for BRCA-Associated Cancers in Rural Public Health Clinics(RSPH5973-23) | recruiting | N/A | 3,209 | Emory UniversityOTHER | 1 | May 26, 2026 | clinicaltrials |
| NCT05225428 | Video Education With Result Dependent dIsclosure(VERDI) | recruiting | N/A | 1,020 | Dana-Farber Cancer InstituteOTHER | 1 | May 22, 2026 | clinicaltrials |
| NCT05649072 | Identifying Underserved Individuals inTexas With Hereditary Cancer Risk Using Mobile Mammography Units and Telegenetics. | recruiting | N/A | 1,000 | M.D. Anderson Cancer CenterOTHER | 1 | May 22, 2026 | clinicaltrials |
| NCT07593339 | Sentinel Lymph Node Mapping in Early-Stage Epithelial Ovarian Cancer Surgery | not yet recruiting | N/A | 30 | Başakşehir Çam & Sakura City HospitalOTHER_GOV | 0 | May 18, 2026 | clinicaltrials |
| NCT07557225 | 18F-T2 PET/CT Imaging for CAIX Positive Solid Tumors | recruiting | N/A | 200 | Peking University First HospitalOTHER | 1 | May 14, 2026 | clinicaltrials |
| NCT04214210 | The DIALOGUE Study: Swiss-Korean Billateral Collaboration(DIALOGUE) | completed | N/A | 128 | University of BaselOTHER | 1 | May 13, 2026 | clinicaltrials |
| NCT07070973 | Proactive Hemodynamic Management During Cytoreductive Surgery and HIPEC(HEMOPEC) | recruiting | N/A | 52 | Fondazione Policlinico Universitario Agostino Gemelli IRCCSOTHER | 1 | May 11, 2026 | clinicaltrials |
| NCT07572409 | Application of Cardiophrenic Lymphadenectomy in Advanced Ovarian Cancer: A Single-Center Prospective Exploratory Study | recruiting | N/A | 52 | manxiaxiaOTHER | 1 | May 7, 2026 | clinicaltrials |
| NCT00539162 | Use of CA125 and Complementary Biomarkers for the Early Detection of Ovarian Cancer in Low Risk Women | recruiting | N/A | 8,000 | M.D. Anderson Cancer CenterOTHER | 1 | May 6, 2026 | clinicaltrials |
| NCT02664389 | Targeted Next-generation Sequencing Panel for Identification of Germline Mutations in Early Onset Cancers With Sporadic or Hereditary Presentation(PANEL) | terminated | N/A | 289 | University Hospital, RouenOTHER | 1 | May 6, 2026 | clinicaltrials |
| NCT04726319 | Family History App in Personalized Medicine(FHAMe) | completed | N/A | 627 | University of TorontoOTHER | 1 | May 6, 2026 | clinicaltrials |
| NCT06466382 | OV Precision: Study Examining the Benefit of a Tumor- and Patient-specific Cancer Therapy(OVPrecision) | recruiting | N/A | 60 | Swiss GO Trial GroupNETWORK | 1 | May 5, 2026 | clinicaltrials |
| NCT07555600 | Enumeration and Functional Analysis of Circulating Tumor Cells for Homologous Recombination: a Prospective Single-center Study on Advanced/Metastatic Solid Tumors(E-FACTOR) | not yet recruiting | N/A | 300 | Centre Leon BerardOTHER | 0 | Apr 29, 2026 | clinicaltrials |
| NCT07555639 | An Integrated Genomic Approach to Assess Genetic Risk and Drug Sensitivity(GERSOM) | active not recruiting | N/A | 4,000 | Fondazione Policlinico Universitario Agostino Gemelli IRCCSOTHER | 1 | Apr 29, 2026 | clinicaltrials |
| NCT06065358 | Ovarian Tumor Organotypic Slices Cultures for functionAl Drug Testing and Therapy Response Prediction(TOSCA) | active not recruiting | N/A | 48 | Fondazione Policlinico Universitario Agostino Gemelli IRCCSOTHER | 1 | Apr 24, 2026 | clinicaltrials |
| NCT01907789 | Prophylactic Salpingectomy With Delayed Oophorectomy | active not recruiting | N/A | 80 | M.D. Anderson Cancer CenterOTHER | 1 | Apr 16, 2026 | clinicaltrials |
| NCT04125914 | Weight Management and Health Behavior Intervention in Lowering Cancer Risk for BRCA Positive and Lynch Syndrome Families | active not recruiting | N/A | 384 | M.D. Anderson Cancer CenterOTHER | 1 | Apr 16, 2026 | clinicaltrials |
| NCT06036810 | Spanish Decision Tool for Ovarian Cancer Maintenance Therapy | recruiting | N/A | 70 | M.D. Anderson Cancer CenterOTHER | 1 | Apr 16, 2026 | clinicaltrials |
| NCT03965481 | PET/MR Versus CECT Scans in Imaging Patients With Ovarian Cancer or Highly Suspected Ovarian Cancer | active not recruiting | N/A | 21 | M.D. Anderson Cancer CenterOTHER | 1 | Apr 15, 2026 | clinicaltrials |
| NCT02854215 | Cost Utility of Radical Surgery in Ovarian Cancer(CURSOC) | completed | N/A | 200 | Institut Claudius RegaudOTHER | 1 | Apr 14, 2026 | clinicaltrials |
| NCT06710548 | REVITALIZE: RCT to Reduce Fatigue in Adults With Ovarian Cancer on PARP Inhibitors | recruiting | N/A | 240 | Dana-Farber Cancer InstituteOTHER | 1 | Apr 13, 2026 | clinicaltrials |
| NCT07000344 | A Study of Apatinib Combined With Letrozole With or Without Fluzoparib in Estrogen Receptor-Positive, Platinum-Sensitive Recurrent Ovarian Cancer Previously Treated With First-Line PARP Inhibitor | terminated | N/A | 5 | Peking Union Medical College HospitalOTHER | 1 | Apr 9, 2026 | clinicaltrials |
| NCT00579514 | Germline Alterations of Tumor Susceptibility Genes in New York Cancer Patients | active not recruiting | N/A | 21,081 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Apr 7, 2026 | clinicaltrials |
| NCT04294927 | TUBectomy With Delayed Oophorectomy in High Risk Women to Assess the Safety of Prevention(TUBA-WISP-II) | recruiting | N/A | 3,000 | University Medical Center NijmegenOTHER | 16 | Apr 6, 2026 | clinicaltrials |
| NCT05752448 | Survivorship Care for Women Living With Ovarian Cancer: (POSTCARE-O)(POSTCARE-O) | recruiting | N/A | 120 | Baylor College of MedicineOTHER | 1 | Apr 3, 2026 | clinicaltrials |
| NCT01977274 | Predictive Clinical and Biological Parameters in Gynecological Cancer(GC-BIO) | active not recruiting | N/A | 300 | Institut Paoli-CalmettesOTHER | 1 | Mar 31, 2026 | clinicaltrials |
| NCT04122235 | The Lifestyle and Empowerment Techniques in Survivorship of Gynecologic Oncology Study(LETSGO) | completed | N/A | 755 | Sorlandet Hospital HFOTHER_GOV | 1 | Mar 30, 2026 | clinicaltrials |
| NCT06969833 | Prospective Clinico-biological Database of Patients With Ovarian and/or Peritoneal and/or Fallopian Tube Carcinoma(BCB-OVAIRE) | recruiting | N/A | 371 | Centre Oscar LambretOTHER | 1 | Mar 30, 2026 | clinicaltrials |
| NCT07241091 | SurgiPerito Trial: High-Purity Type-I Collagen for Peritoneal Reconstruction After Cytoreductive Surgery | completed | N/A | 60 | Adichunchanagiri Institute of Medical Sciences, B G NagaraOTHER | 1 | Mar 30, 2026 | clinicaltrials |
| NCT07495384 | Efficacy and Safety of CapsuleX Combined With Cisplatin in Platinum-Resistant Recurrent Ovarian Cancer: A Single-Arm Prospective Clinical Study | recruiting | N/A | 40 | The First Hospital of Jilin UniversityOTHER | 1 | Mar 27, 2026 | clinicaltrials |
| NCT07495397 | Single-arm, Prospective Clinical Trial of Efficacy and Safety of Daphnetin Capsules Combined With TC Regimen for Targeted Maintenance Therapy After Initial Treatment of Stage III-IV Epithelial Ovarian Cancer (RO/R1) | recruiting | N/A | 98 | The First Hospital of Jilin UniversityOTHER | 1 | Mar 27, 2026 | clinicaltrials |
| NCT07491081 | EARLY Study: Evaluating the Specificity and Feasibility of the EARLY Biomarker Panel for Ovarian Cancer Detection | recruiting | N/A | 1,500 | Queensland Centre for Gynaecological CancerOTHER_GOV | 1 | Mar 24, 2026 | clinicaltrials |
| NCT06662435 | GYNecologic Cancer-Related COGnitive Impairment(GYNCOG) | completed | N/A | 60 | Northwestern UniversityOTHER | 1 | Mar 23, 2026 | clinicaltrials |
| NCT03010124 | Prognostic and Predictive Biomarkers in Ovarian Cancers(OvBIOMark) | recruiting | N/A | 350 | Gustave Roussy, Cancer Campus, Grand ParisOTHER | 1 | Mar 20, 2026 | clinicaltrials |
| NCT03922776 | Phenotypic Characterization Tumor-infiltrating Lymphocytes at Diagnosis and After Chemotherapy in Ovarian Cancer(TILsOV) | terminated | N/A | 36 | Centre Oscar LambretOTHER | 1 | Mar 18, 2026 | clinicaltrials |
| NCT06422455 | Access to Genetic Testing in Underserved Patients With Cancer | recruiting | N/A | 800 | University of Southern CaliforniaOTHER | 1 | Mar 18, 2026 | clinicaltrials |
| NCT07480785 | TEAS Combined With Triple Antiemetic Drugs to Prevent PONV in High-Risk Patients | recruiting | N/A | 780 | Zhejiang UniversityOTHER | 1 | Mar 18, 2026 | clinicaltrials |
| NCT07455071 | A Single-center, Dose-escalation Clinical Study to Evaluate the Safety, Tolerability and Preliminary Efficacy of Tumor Neoantigen-pulsed Autologous Dendritic Cell Injection (YS247) in Study Participants With HRD-negative Epithelial Ovarian Cancer(YS247) | not yet recruiting | N/A | 9 | Peking University Third HospitalOTHER | 0 | Mar 16, 2026 | clinicaltrials |
| NCT01247779 | Perioperative Morbidity in Gyneco-oncology According to the Procedure : Coelioscopy Versus Robot-assisted Coelioscopy(ROBO-GYN) | completed | N/A | 386 | Centre Oscar LambretOTHER | 1 | Mar 13, 2026 | clinicaltrials |
Data updated 22 days agoSource updated Jun 11, 2026source: clinicaltrials